7 result(s) displayed (1 - 7 of 7):

Tobin leaves Boston Sci dented by deals (from Corporate Dealmaker)

Few people in the M&A world need to be reminded that acquisitions often go wrong. But it's still useful to reflect on the ways that can happen. And the retirement of Jim Tobin as CEO of medical devices maker Boston Scientific Corp. (NYSE:BSX), announced Thursday, is a good occasion to...

Posted on June 25, 2009 12:16 PM

Hiring: Centerview grabs Merrill healthcare M&A bankers (from Corporate Dealmaker)

The healthcare industry is restructuring itself to reduce its reliance on blockbuster drugs while trying to gain a foothold in the generics market and the emerging markets. We've seen megamergers and bolt-ons, and there's more to come. New York boutique investment bank Centerview Partners LLC is right on top of...

Posted on April 15, 2009 12:47 PM

How Lehman bankruptcy forced insider sales at Boston Scientific (from Corporate Dealmaker)

Usually it's unnerving when the founders of a company you have a stake in dump their shares. In the current market, when they're apparently doing it against their will, it's just weird. On Thursday, Boston Scientific Corp.'s stock traded abnormally heavily, with 38 million shares changing hands. The total included...

Posted on October 10, 2008 4:45 PM

Angiotech's spinout strategy (from Corporate Dealmaker)

As we noted on Monday, spinning off assets is becoming a popular strategy for companies trying to streamline their businesses in a difficult economy. The latest to do so is Angiotech Pharmaceuticals Inc., which is spinning off its medical products into a subsidiary. Ongoing royalties from Angiotech's coronary drug-eluting stent...

Posted on July 8, 2008 9:18 AM

Abbott: No big deals, maybe some opportunistic ones (from Corporate Dealmaker)

Major acquisitions aren't ahead for Abbot Laboratories, CEO Miles White told investors on a conference call Wednesday, according to this Reuters story. But that doesn't rule out what White described as "opportunistic" deals. In that department, White surely knows what he's talking about. In the epic 2005 battle between Johnson...

Posted on January 23, 2008 4:12 PM

Corporate Venture Capital: Medical Device Mania (from Corporate Dealmaker)

"At Guidant, we never made an investment at any company without the notion that if things went well, we would acquire it."

Posted on August 15, 2007 4:55 PM

The Boston Sci-Guidant deal revisited (from Corporate Dealmaker)

Viewed from a patent perspective, the acquisition makes a little more sense -- for both offensive and defensive reasons.

Posted on December 15, 2006 10:02 PM